experience
With respect to their academic background, most participants (n = 9) had a PhD, three (3) had a post-doctorate, two (2) had a master’s degree, and two (2) had a bachelor’s degree. Participants came from a variety of disciplines: nine (9) had a specialty in the humanities or social sciences, four (4) in the health sciences and three (3) in the natural sciences. In terms of their knowledge of ethics, five (5) participants reported having taken one university course entirely dedicated to ethics, four (4) reported having taken several university courses entirely dedicated to ethics, three (3) had a university degree dedicated to ethics, while two (2) only had a few hours or days of training in ethics and two (2) reported having no knowledge of ethics.
As Fig. 1 illustrates, ten units of meaning emerge from the data analysis, namely: (1) research integrity, (2) conflicts of interest, (3) respect for research participants, (4) lack of supervision and power imbalances, (5) individualism and performance, (6) inadequate ethical guidance, (7) social injustices, (8) distributive injustices, (9) epistemic injustices, and (10) ethical distress. To illustrate the results, excerpts from verbatim interviews are presented in the following sub-sections. Most of the excerpts have been translated into English as the majority of interviews were conducted with French-speaking participants.
Ethical issues in research according to the participants
The research environment is highly competitive and performance-based. Several participants, in particular researchers and research ethics experts, felt that this environment can lead both researchers and research teams to engage in unethical behaviour that reflects a lack of research integrity. For example, as some participants indicated, competition for grants and scientific publications is sometimes so intense that researchers falsify research results or plagiarize from colleagues to achieve their goals.
Some people will lie or exaggerate their research findings in order to get funding. Then, you see it afterwards, you realize: “ah well, it didn’t work, but they exaggerated what they found and what they did” (participant 14). Another problem in research is the identification of authors when there is a publication. Very often, there are authors who don’t even know what the publication is about and that their name is on it. (…) The time that it surprised me the most was just a few months ago when I saw someone I knew who applied for a teaching position. He got it I was super happy for him. Then I looked at his publications and … there was one that caught my attention much more than the others, because I was in it and I didn’t know what that publication was. I was the second author of a publication that I had never read (participant 14). I saw a colleague who had plagiarized another colleague. [When the colleague] found out about it, he complained. So, plagiarism is a serious [ethical breach]. I would also say that there is a certain amount of competition in the university faculties, especially for grants (…). There are people who want to win at all costs or get as much as possible. They are not necessarily going to consider their colleagues. They don’t have much of a collegial spirit (participant 10).
These examples of research misbehaviour or misconduct are sometimes due to or associated with situations of conflicts of interest, which may be poorly managed by certain researchers or research teams, as noted by many participants.
The actors and institutions involved in research have diverse interests, like all humans and institutions. As noted in Chap. 7 of the Canadian Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS2, 2018),
“researchers and research students hold trust relationships, either directly or indirectly, with participants, research sponsors, institutions, their professional bodies and society. These trust relationships can be put at risk by conflicts of interest that may compromise independence, objectivity or ethical duties of loyalty. Although the potential for such conflicts has always existed, pressures on researchers (i.e., to delay or withhold dissemination of research outcomes or to use inappropriate recruitment strategies) heighten concerns that conflicts of interest may affect ethical behaviour” (p. 92).
The sources of these conflicts are varied and can include interpersonal conflicts, financial partnerships, third-party pressures, academic or economic interests, a researcher holding multiple roles within an institution, or any other incentive that may compromise a researcher’s independence, integrity, and neutrality (TCPS2, 2018). While it is not possible to eliminate all conflicts of interest, it is important to manage them properly and to avoid temptations to behave unethically.
Ethical temptations correspond to situations in which people are tempted to prioritize their own interests to the detriment of the ethical goods that should, in their own context, govern their actions (Swisher et al., 2005 ). In the case of researchers, this refers to situations that undermine independence, integrity, neutrality, or even the set of principles that govern research ethics (TCPS2, 2018) or the responsible conduct of research. According to study participants, these types of ethical issues frequently occur in research. Many participants, especially researchers and REB members, reported that conflicts of interest can arise when members of an organization make decisions to obtain large financial rewards or to increase their academic profile, often at the expense of the interests of members of their research team, research participants, or even the populations affected by their research.
A company that puts money into making its drug work wants its drug to work. So, homeopathy is a good example, because there are not really any consequences of homeopathy, there are not very many side effects, because there are no effects at all. So, it’s not dangerous, but it’s not a good treatment either. But some people will want to make it work. And that’s a big issue when you’re sitting at a table and there are eight researchers, and there are two or three who are like that, and then there are four others who are neutral, and I say to myself, this is not science. I think that this is a very big ethical issue (participant 14). There are also times in some research where there will be more links with pharmaceutical companies. Obviously, there are then large amounts of money that will be very interesting for the health-care institutions because they still receive money for clinical trials. They’re still getting some compensation because its time consuming for the people involved and all that. The pharmaceutical companies have money, so they will compensate, and that is sometimes interesting for the institutions, and since we are a bit caught up in this, in the sense that we have no choice but to accept it. (…) It may not be the best research in the world, there may be a lot of side effects due to the drugs, but it’s good to accept it, we’re going to be part of the clinical trial (participant 3). It is integrity, what we believe should be done or said. Often by the pressure of the environment, integrity is in tension with the pressures of the environment, so it takes resistance, it takes courage in research. (…) There were all the debates there about the problems of research that was funded and then the companies kept control over what was written. That was really troubling for a lot of researchers (participant 5).
Further, these situations sometimes have negative consequences for research participants as reported by some participants.
Many research projects, whether they are psychosocial or biomedical in nature, involve human participants. Relationships between the members of research teams and their research participants raise ethical issues that can be complex. Research projects must always be designed to respect the rights and interests of research participants, and not just those of researchers. However, participants in our study – i.e., REB members, researchers, and research ethics experts – noted that some research teams seem to put their own interests ahead of those of research participants. They also emphasized the importance of ensuring the respect, well-being, and safety of research participants. The ethical issues related to this unit of meaning are: respect for free, informed and ongoing consent of research participants; respect for and the well-being of participants; data protection and confidentiality; over-solicitation of participants; ownership of the data collected on participants; the sometimes high cost of scientific innovations and their accessibility; balance between the social benefits of research and the risks to participants (particularly in terms of safety); balance between collective well-being (development of knowledge) and the individual rights of participants; exploitation of participants; paternalism when working with populations in vulnerable situations; and the social acceptability of certain types of research. The following excerpts present some of these issues.
Where it disturbs me ethically is in the medical field – because it’s more in the medical field that we’re going to see this – when consent forms are presented to patients to solicit them as participants, and then [these forms] have an average of 40 pages. That annoys me. When they say that it has to be easy to understand and all that, adapted to the language, and then the hyper-technical language plus there are 40 pages to read, I don’t understand how you’re going to get informed consent after reading 40 pages. (…) For me, it doesn’t work. I read them to evaluate them and I have a certain level of education and experience in ethics, and there are times when I don’t understand anything (participant 2). There is a lot of pressure from researchers who want to recruit research participants (…). The idea that when you enter a health care institution, you become a potential research participant, when you say “yes to a research, you check yes to all research”, then everyone can ask you. I think that researchers really have this fantasy of saying to themselves: “as soon as people walk through the door of our institution, they become potential participants with whom we can communicate and get them involved in all projects”. There’s a kind of idea that, yes, it can be done, but it has to be somewhat supervised to avoid over-solicitation (…). Researchers are very interested in facilitating recruitment and making it more fluid, but perhaps to the detriment of confidentiality, privacy, and respect; sometimes that’s what it is, to think about what type of data you’re going to have in your bank of potential participants? Is it just name and phone number or are you getting into more sensitive information? (participant 9).
In addition, one participant reported that their university does not provide the resources required to respect the confidentiality of research participants.
The issue is as follows: researchers, of course, commit to protecting data with passwords and all that, but we realize that in practice, it is more difficult. It is not always as protected as one might think, because professor-researchers will run out of space. Will the universities make rooms available to researchers, places where they can store these things, especially when they have paper documentation, and is there indeed a guarantee of confidentiality? Some researchers have told me: “Listen; there are even filing cabinets in the corridors”. So, that certainly poses a concrete challenge. How do we go about challenging the administrative authorities? Tell them it’s all very well to have an ethics committee, but you have to help us, you also have to make sure that the necessary infrastructures are in place so that what we are proposing is really put into practice (participant 4).
If the relationships with research participants are likely to raise ethical issues, so too are the relationships with students, notably research assistants. On this topic, several participants discussed the lack of supervision or recognition offered to research assistants by researchers as well as the power imbalances between members of the research team.
Many research teams are composed not only of researchers, but also of students who work as research assistants. The relationship between research assistants and other members of research teams can sometimes be problematic and raise ethical issues, particularly because of the inevitable power asymmetries. In the context of this study, several participants – including a research assistant, REB members, and researchers – discussed the lack of supervision or recognition of the work carried out by students, psychological pressure, and the more or less well-founded promises that are sometimes made to students. Participants also mentioned the exploitation of students by certain research teams, which manifest when students are inadequately paid, i.e., not reflective of the number of hours actually worked, not a fair wage, or even a wage at all.
[As a research assistant], it was more of a feeling of distress that I felt then because I didn’t know what to do. (…) I was supposed to get coaching or be supported, but I didn’t get anything in the end. It was like, “fix it by yourself”. (…) All research assistants were supposed to be supervised, but in practice they were not (participant 1). Very often, we have a master’s or doctoral student that we put on a subject and we consider that the project will be well done, while the student is learning. So, it happens that the student will do a lot of work and then we realize that the work is poorly done, and it is not necessarily the student’s fault. He wasn’t necessarily well supervised. There are directors who have 25 students, and they just don’t supervise them (participant 14). I think it’s really the power relationship. I thought to myself, how I saw my doctorate, the beginning of my research career, I really wanted to be in that laboratory, but they are the ones who are going to accept me or not, so what do I do to be accepted? I finally accept their conditions [which was to work for free]. If these are the conditions that are required to enter this lab, I want to go there. So, what do I do, well I accepted. It doesn’t make sense, but I tell myself that I’m still privileged, because I don’t have so many financial worries, one more reason to work for free, even though it doesn’t make sense (participant 1). In research, we have research assistants. (…). The fact of using people… so that’s it, you have to take into account where they are, respect them, but at the same time they have to show that they are there for the research. In English, we say “carry” or take care of people. With research assistants, this is often a problem that I have observed: for grant machines, the person is the last to be found there. Researchers, who will take, use student data, without giving them the recognition for it (participant 5). The problem at our university is that they reserve funding for Canadian students. The doctoral clientele in my field is mostly foreign students. So, our students are poorly funded. I saw one student end up in the shelter, in a situation of poverty. It ended very badly for him because he lacked financial resources. Once you get into that dynamic, it’s very hard to get out. I was made aware of it because the director at the time had taken him under her wing and wanted to try to find a way to get him out of it. So, most of my students didn’t get funded (participant 16). There I wrote “manipulation”, but it’s kind of all promises all the time. I, for example, was promised a lot of advancement, like when I got into the lab as a graduate student, it was said that I had an interest in [this particular area of research]. I think there are a lot of graduate students who must have gone through that, but it is like, “Well, your CV has to be really good, if you want to do a lot of things and big things. If you do this, if you do this research contract, the next year you could be the coordinator of this part of the lab and supervise this person, get more contracts, be paid more. Let’s say: you’ll be invited to go to this conference, this big event”. They were always dangling something, but you have to do that first to get there. But now, when you’ve done that, you have to do this business. It’s like a bit of manipulation, I think. That was very hard to know who is telling the truth and who is not (participant 1).
These ethical issues have significant negative consequences for students. Indeed, they sometimes find themselves at the mercy of researchers, for whom they work, struggling to be recognized and included as authors of an article, for example, or to receive the salary that they are due. For their part, researchers also sometimes find themselves trapped in research structures that can negatively affect their well-being. As many participants reported, researchers work in organizations that set very high productivity standards and in highly competitive contexts, all within a general culture characterized by individualism.
Participants, especially researchers, discussed the culture of individualism and performance that characterizes the academic environment. In glorifying excellence, some universities value performance and productivity, often at the expense of psychological well-being and work-life balance (i.e., work overload and burnout). Participants noted that there are ethical silences in their organizations on this issue, and that the culture of individualism and performance is not challenged for fear of retribution or simply to survive, i.e., to perform as expected. Participants felt that this culture can have a significant negative impact on the quality of the research conducted, as research teams try to maximize the quantity of their work (instead of quality) in a highly competitive context, which is then exacerbated by a lack of resources and support, and where everything must be done too quickly.
The work-life balance with the professional ethics related to work in a context where you have too much and you have to do a lot, it is difficult to balance all that and there is a lot of pressure to perform. If you don’t produce enough, that’s it; after that, you can’t get any more funds, so that puts pressure on you to do more and more and more (participant 3). There is a culture, I don’t know where it comes from, and that is extremely bureaucratic. If you dare to raise something, you’re going to have many, many problems. They’re going to make you understand it. So, I don’t talk. It is better: your life will be easier. I think there are times when you have to talk (…) because there are going to be irreparable consequences. (…) I’m not talking about a climate of terror, because that’s exaggerated, it’s not true, people are not afraid. But people close their office door and say nothing because it’s going to make their work impossible and they’re not going to lose their job, they’re not going to lose money, but researchers need time to be focused, so they close their office door and say nothing (participant 16).
Researchers must produce more and more, and they feel little support in terms of how to do such production, ethically, and how much exactly they are expected to produce. As this participant reports, the expectation is an unspoken rule: more is always better.
It’s sometimes the lack of a clear line on what the expectations are as a researcher, like, “ah, we don’t have any specific expectations, but produce, produce, produce, produce.” So, in that context, it’s hard to be able to put the line precisely: “have I done enough for my work?” (participant 3).
While the productivity expectation is not clear, some participants – including researchers, research ethics experts, and REB members – also felt that the ethical expectations of some REBs were unclear. The issue of the inadequate ethical guidance of research includes the administrative mechanisms to ensure that research projects respect the principles of research ethics. According to those participants, the forms required for both researchers and REB members are increasingly long and numerous, and one participant noted that the standards to be met are sometimes outdated and disconnected from the reality of the field. Multicentre ethics review (by several REBs) was also critiqued by a participant as an inefficient method that encumbers the processes for reviewing research projects. Bureaucratization imposes an ever-increasing number of forms and ethics guidelines that actually hinder researchers’ ethical reflection on the issues at stake, leading the ethics review process to be perceived as purely bureaucratic in nature.
The ethical dimension and the ethical review of projects have become increasingly bureaucratized. (…) When I first started working (…) it was less bureaucratic, less strict then. I would say [there are now] tons of forms to fill out. Of course, we can’t do without it, it’s one of the ways of marking out ethics and ensuring that there are ethical considerations in research, but I wonder if it hasn’t become too bureaucratized, so that it’s become a kind of technical reflex to fill out these forms, and I don’t know if people really do ethical reflection as such anymore (participant 10). The fundamental structural issue, I would say, is the mismatch between the normative requirements and the real risks posed by the research, i.e., we have many, many requirements to meet; we have very long forms to fill out but the research projects we evaluate often pose few risks (participant 8). People [in vulnerable situations] were previously unable to participate because of overly strict research ethics rules that were to protect them, but in the end [these rules] did not protect them. There was a perverse effect, because in the end there was very little research done with these people and that’s why we have very few results, very little evidence [to support practices with these populations] so it didn’t improve the quality of services. (…) We all understand that we have to be careful with that, but when the research is not too risky, we say to ourselves that it would be good because for once a researcher who is interested in that population, because it is not a very popular population, it would be interesting to have results, but often we are blocked by the norms, and then we can’t accept [the project] (participant 2).
Moreover, as one participant noted, accessing ethics training can be a challenge.
There is no course on research ethics. […] Then, I find that it’s boring because you go through university and you come to do your research and you know how to do quantitative and qualitative research, but all the research ethics, where do you get this? I don’t really know (participant 13).
Yet, such training could provide relevant tools to resolve, to some extent, the ethical issues that commonly arise in research. That said, and as noted by many participants, many ethical issues in research are related to social injustices over which research actors have little influence.
For many participants, notably researchers, the issues that concern social injustices are those related to power asymmetries, stigma, or issues of equity, diversity, and inclusion, i.e., social injustices related to people’s identities (Blais & Drolet, 2022 ). Participants reported experiencing or witnessing discrimination from peers, administration, or lab managers. Such oppression is sometimes cross-sectional and related to a person’s age, cultural background, gender or social status.
I have my African colleague who was quite successful when he arrived but had a backlash from colleagues in the department. I think it’s unconscious, nobody is overtly racist. But I have a young person right now who is the same, who has the same success, who got exactly the same early career award and I don’t see the same backlash. He’s just as happy with what he’s doing. It’s normal, they’re young and they have a lot of success starting out. So, I think there is discrimination. Is it because he is African? Is it because he is black? I think it’s on a subconscious level (participant 16).
Social injustices were experienced or reported by many participants, and included issues related to difficulties in obtaining grants or disseminating research results in one’s native language (i.e., even when there is official bilingualism) or being considered credible and fundable in research when one researcher is a woman.
If you do international research, there are things you can’t talk about (…). It is really a barrier to research to not be able to (…) address this question [i.e. the question of inequalities between men and women]. Women’s inequality is going to be addressed [but not within the country where the research takes place as if this inequality exists elsewhere but not here]. There are a lot of women working on inequality issues, doing work and it’s funny because I was talking to a young woman who works at Cairo University and she said to me: “Listen, I saw what you had written, you’re right. I’m willing to work on this but guarantee me a position at your university with a ticket to go”. So yes, there are still many barriers [for women in research] (participant 16).
Because of the varied contextual characteristics that intervene in their occurrence, these social injustices are also related to distributive injustices, as discussed by many participants.
Although there are several views of distributive justice, a classical definition such as that of Aristotle ( 2012 ), describes distributive justice as consisting in distributing honours, wealth, and other social resources or benefits among the members of a community in proportion to their alleged merit. Justice, then, is about determining an equitable distribution of common goods. Contemporary theories of distributive justice are numerous and varied. Indeed, many authors (e.g., Fraser 2011 ; Mills, 2017 ; Sen, 2011 ; Young, 2011 ) have, since Rawls ( 1971 ), proposed different visions of how social burdens and benefits should be shared within a community to ensure equal respect, fairness, and distribution. In our study, what emerges from participants’ narratives is a definite concern for this type of justice. Women researchers, francophone researchers, early career researchers or researchers belonging to racialized groups all discussed inequities in the distribution of research grants and awards, and the extra work they need to do to somehow prove their worth. These inequities are related to how granting agencies determine which projects will be funded.
These situations make me work 2–3 times harder to prove myself and to show people in power that I have a place as a woman in research (participant 12). Number one: it’s conservative thinking. The older ones control what comes in. So, the younger people have to adapt or they don’t get funded (participant 14).
Whether it is discrimination against stigmatized or marginalized populations or interest in certain hot topics, granting agencies judge research projects according to criteria that are sometimes questionable, according to those participants. Faced with difficulties in obtaining funding for their projects, several strategies – some of which are unethical – are used by researchers in order to cope with these situations.
Sometimes there are subjects that everyone goes to, such as nanotechnology (…), artificial intelligence or (…) the therapeutic use of cannabis, which are very fashionable, and this is sometimes to the detriment of other research that is just as relevant, but which is (…), less sexy, less in the spirit of the time. (…) Sometimes this can lead to inequities in the funding of certain research sectors (participant 9). When we use our funds, we get them given to us, we pretty much say what we think we’re going to do with them, but things change… So, when these things change, sometimes it’s an ethical decision, but by force of circumstances I’m obliged to change the project a little bit (…). Is it ethical to make these changes or should I just let the money go because I couldn’t use it the way I said I would? (participant 3).
Moreover, these distributional injustices are not only linked to social injustices, but also epistemic injustices. Indeed, the way in which research honours and grants are distributed within the academic community depends on the epistemic authority of the researchers, which seems to vary notably according to their language of use, their age or their gender, but also to the research design used (inductive versus deductive), their decision to use (or not use) animals in research, or to conduct activist research.
The philosopher Fricker ( 2007 ) conceptualized the notions of epistemic justice and injustice. Epistemic injustice refers to a form of social inequality that manifests itself in the access, recognition, and production of knowledge as well as the various forms of ignorance that arise (Godrie & Dos Santos, 2017 ). Addressing epistemic injustice necessitates acknowledging the iniquitous wrongs suffered by certain groups of socially stigmatized individuals who have been excluded from knowledge, thus limiting their abilities to interpret, understand, or be heard and account for their experiences. In this study, epistemic injustices were experienced or reported by some participants, notably those related to difficulties in obtaining grants or disseminating research results in one’s native language (i.e., even when there is official bilingualism) or being considered credible and fundable in research when a researcher is a woman or an early career researcher.
I have never sent a grant application to the federal government in English. I have always done it in French, even though I know that when you receive the review, you can see that reviewers didn’t understand anything because they are English-speaking. I didn’t want to get in the boat. It’s not my job to translate, because let’s be honest, I’m not as good in English as I am in French. So, I do them in my first language, which is the language I’m most used to. Then, technically at the administrative level, they are supposed to be able to do it, but they are not good in French. (…) Then, it’s a very big Canadian ethical issue, because basically there are technically two official languages, but Canada is not a bilingual country, it’s a country with two languages, either one or the other. (…) So I was not funded (participant 14).
Researchers who use inductive (or qualitative) methods observed that their projects are sometimes less well reviewed or understood, while research that adopts a hypothetical-deductive (or quantitative) or mixed methods design is better perceived, considered more credible and therefore more easily funded. Of course, regardless of whether a research project adopts an inductive, deductive or mixed-methods scientific design, or whether it deals with qualitative or quantitative data, it must respect a set of scientific criteria. A research project should achieve its objectives by using proven methods that, in the case of inductive research, are credible, reliable, and transferable or, in the case of deductive research, generalizable, objective, representative, and valid (Drolet & Ruest, accepted ). Participants discussing these issues noted that researchers who adopt a qualitative design or those who question the relevance of animal experimentation or are not militant have sometimes been unfairly devalued in their epistemic authority.
There is a mini war between quantitative versus qualitative methods, which I think is silly because science is a method. If you apply the method well, it doesn’t matter what the field is, it’s done well and it’s perfect ” (participant 14). There is also the issue of the place of animals in our lives, because for me, ethics is human ethics, but also animal ethics. Then, there is a great evolution in society on the role of the animal… with the new law that came out in Quebec on the fact that animals are sensitive beings. Then, with the rise of the vegan movement, [we must ask ourselves]: “Do animals still have a place in research?” That’s a big question and it also means that there are practices that need to evolve, but sometimes there’s a disconnection between what’s expected by research ethics boards versus what’s expected in the field (participant 15). In research today, we have more and more research that is militant from an ideological point of view. And so, we have researchers, because they defend values that seem important to them, we’ll talk for example about the fight for equality and social justice. They have pressure to defend a form of moral truth and have the impression that everyone thinks like them or should do so, because they are defending a moral truth. This is something that we see more and more, namely the lack of distance between ideology and science (participant 8).
The combination or intersectionality of these inequities, which seems to be characterized by a lack of ethical support and guidance, is experienced in the highly competitive and individualistic context of research; it provides therefore the perfect recipe for researchers to experience ethical distress.
The concept of “ethical distress” refers to situations in which people know what they should do to act ethically, but encounter barriers, generally of an organizational or systemic nature, limiting their power to act according to their moral or ethical values (Drolet & Ruest, 2021 ; Jameton, 1984 ; Swisher et al., 2005 ). People then run the risk of finding themselves in a situation where they do not act as their ethical conscience dictates, which in the long term has the potential for exhaustion and distress. The examples reported by participants in this study point to the fact that researchers in particular may be experiencing significant ethical distress. This distress takes place in a context of extreme competition, constant injunctions to perform, and where administrative demands are increasingly numerous and complex to complete, while paradoxically, they lack the time to accomplish all their tasks and responsibilities. Added to these demands are a lack of resources (human, ethical, and financial), a lack of support and recognition, and interpersonal conflicts.
We are in an environment, an elite one, you are part of it, you know what it is: “publish or perish” is the motto. Grants, there is a high level of performance required, to do a lot, to publish, to supervise students, to supervise them well, so yes, it is clear that we are in an environment that is conducive to distress. (…). Overwork, definitely, can lead to distress and eventually to exhaustion. When you know that you should take the time to read the projects before sharing them, but you don’t have the time to do that because you have eight that came in the same day, and then you have others waiting… Then someone rings a bell and says: “ah but there, the protocol is a bit incomplete”. Oh yes, look at that, you’re right. You make up for it, but at the same time it’s a bit because we’re in a hurry, we don’t necessarily have the resources or are able to take the time to do things well from the start, we have to make up for it later. So yes, it can cause distress (participant 9). My organization wanted me to apply in English, and I said no, and everyone in the administration wanted me to apply in English, and I always said no. Some people said: “Listen, I give you the choice”, then some people said: “Listen, I agree with you, but if you’re not [submitting] in English, you won’t be funded”. Then the fact that I am young too, because very often they will look at the CV, they will not look at the project: “ah, his CV is not impressive, we will not finance him”. This is complete nonsense. The person is capable of doing the project, the project is fabulous: we fund the project. So, that happened, organizational barriers: that happened a lot. I was not eligible for Quebec research funds (…). I had big organizational barriers unfortunately (participant 14). At the time of my promotion, some colleagues were not happy with the type of research I was conducting. I learned – you learn this over time when you become friends with people after you enter the university – that someone was against me. He had another candidate in mind, and he was angry about the selection. I was under pressure for the first three years until my contract was renewed. I almost quit at one point, but another colleague told me, “No, stay, nothing will happen”. Nothing happened, but these issues kept me awake at night (participant 16).
This difficult context for many researchers affects not only the conduct of their own research, but also their participation in research. We faced this problem in our study, despite the use of multiple recruitment methods, including more than 200 emails – of which 191 were individual solicitations – sent to potential participants by the two research assistants. REB members and organizations overseeing or supporting research (n = 17) were also approached to see if some of their employees would consider participating. While it was relatively easy to recruit REB members and research ethics experts, our team received a high number of non-responses to emails (n = 175) and some refusals (n = 5), especially by researchers. The reasons given by those who replied were threefold: (a) fear of being easily identified should they take part in the research, (b) being overloaded and lacking time, and (c) the intrusive aspect of certain questions (i.e., “Have you experienced a burnout episode? If so, have you been followed up medically or psychologically?”). In light of these difficulties and concerns, some questions in the socio-demographic questionnaire were removed or modified. Talking about burnout in research remains a taboo for many researchers, which paradoxically can only contribute to the unresolved problem of unhealthy research environments.
The question that prompted this research was: What are the ethical issues in research? The purpose of the study was to describe these issues from the perspective of researchers (from different disciplines), research ethics board (REB) members, and research ethics experts. The previous section provided a detailed portrait of the ethical issues experienced by different research stakeholders: these issues are numerous, diverse and were recounted by a range of stakeholders.
The results of the study are generally consistent with the literature. For example, as in our study, the literature discusses the lack of research integrity on the part of some researchers (Al-Hidabi et al., 2018 ; Swazey et al., 1993 ), the numerous conflicts of interest experienced in research (Williams-Jones et al., 2013 ), the issues of recruiting and obtaining the free and informed consent of research participants (Provencher et al., 2014 ; Keogh & Daly, 2009 ), the sometimes difficult relations between researchers and REBs (Drolet & Girard, 2020 ), the epistemological issues experienced in research (Drolet & Ruest, accepted; Sieber 2004 ), as well as the harmful academic context in which researchers evolve, insofar as this is linked to a culture of performance, an overload of work in a context of accountability (Berg & Seeber, 2016 ; FQPPU; 2019 ) that is conducive to ethical distress and even burnout.
If the results of the study are generally in line with those of previous publications on the subject, our findings also bring new elements to the discussion while complementing those already documented. In particular, our results highlight the role of systemic injustices – be they social, distributive or epistemic – within the environments in which research is carried out, at least in Canada. To summarize, the results of our study point to the fact that the relationships between researchers and research participants are likely still to raise worrying ethical issues, despite widely accepted research ethics norms and institutionalized review processes. Further, the context in which research is carried out is not only conducive to breaches of ethical norms and instances of misbehaviour or misconduct, but also likely to be significantly detrimental to the health and well-being of researchers, as well as research assistants. Another element that our research also highlighted is the instrumentalization and even exploitation of students and research assistants, which is another important and worrying social injustice given the inevitable power imbalances between students and researchers.
Moreover, in a context in which ethical issues are often discussed from a micro perspective, our study helps shed light on both the micro- and macro-level ethical dimensions of research (Bronfenbrenner, 1979 ; Glaser 1994 ). However, given that ethical issues in research are not only diverse, but also and above all complex, a broader perspective that encompasses the interplay between the micro and macro dimensions can enable a better understanding of these issues and thereby support the identification of the multiple factors that may be at their origin. Triangulating the perspectives of researchers with those of REB members and research ethics experts enabled us to bring these elements to light, and thus to step back from and critique the way that research is currently conducted. To this end, attention to socio-political elements such as the performance culture in academia or how research funds are distributed, and according to what explicit and implicit criteria, can contribute to identifying the sources of the ethical issues described above.
The German sociologist and philosopher Rosa (2010) argues that late modernity – that is, the period between the 1980s and today – is characterized by a phenomenon of social acceleration that causes various forms of alienation in our relationship to time, space, actions, things, others and ourselves. Rosa distinguishes three types of acceleration: technical acceleration , the acceleration of social changes and the acceleration of the rhythm of life . According to Rosa, social acceleration is the main problem of late modernity, in that the invisible social norm of doing more and faster to supposedly save time operates unchallenged at all levels of individual and collective life, as well as organizational and social life. Although we all, researchers and non-researchers alike, perceive this unspoken pressure to be ever more productive, the process of social acceleration as a new invisible social norm is our blind spot, a kind of tyrant over which we have little control. This conceptualization of the contemporary culture can help us to understand the context in which research is conducted (like other professional practices). To this end, Berg & Seeber ( 2016 ) invite faculty researchers to slow down in order to better reflect and, in the process, take care of their health and their relationships with their colleagues and students. Many women professors encourage their fellow researchers, especially young women researchers, to learn to “say No” in order to protect their mental and physical health and to remain in their academic careers (Allaire & Descheneux, 2022 ). These authors also remind us of the relevance of Kahneman’s ( 2012 ) work which demonstrates that it takes time to think analytically, thoroughly, and logically. Conversely, thinking quickly exposes humans to cognitive and implicit biases that then lead to errors in thinking (e.g., in the analysis of one’s own research data or in the evaluation of grant applications or student curriculum vitae). The phenomenon of social acceleration, which pushes the researcher to think faster and faster, is likely to lead to unethical bad science that can potentially harm humankind. In sum, Rosa’s invitation to contemporary critical theorists to seriously consider the problem of social acceleration is particularly insightful to better understand the ethical issues of research. It provides a lens through which to view the toxic context in which research is conducted today, and one that was shared by the participants in our study.
Clark & Sousa ( 2022 ) note, it is important that other criteria than the volume of researchers’ contributions be valued in research, notably quality. Ultimately, it is the value of the knowledge produced and its influence on the concrete lives of humans and other living beings that matters, not the quantity of publications. An interesting articulation of this view in research governance is seen in a change in practice by Australia’s national health research funder: they now restrict researchers to listing on their curriculum vitae only the top ten publications from the past ten years (rather than all of their publications), in order to evaluate the quality of contributions rather than their quantity. To create environments conducive to the development of quality research, it is important to challenge the phenomenon of social acceleration, which insidiously imposes a quantitative normativity that is both alienating and detrimental to the quality and ethical conduct of research. Based on our experience, we observe that the social norm of acceleration actively disfavours the conduct of empirical research on ethics in research. The fact is that researchers are so busy that it is almost impossible for them to find time to participate in such studies. Further, operating in highly competitive environments, while trying to respect the values and ethical principles of research, creates ethical paradoxes for members of the research community. According to Malherbe ( 1999 ), an ethical paradox is a situation where an individual is confronted by contradictory injunctions (i.e., do more, faster, and better). And eventually, ethical paradoxes lead individuals to situations of distress and burnout, or even to ethical failures (i.e., misbehaviour or misconduct) in the face of the impossibility of responding to contradictory injunctions.
The triangulation of perceptions and experiences of different actors involved in research is a strength of our study. While there are many studies on the experiences of researchers, rarely are members of REBs and experts in research ethics given the space to discuss their views of what are ethical issues. Giving each of these stakeholders a voice and comparing their different points of view helped shed a different and complementary light on the ethical issues that occur in research. That said, it would have been helpful to also give more space to issues experienced by students or research assistants, as the relationships between researchers and research assistants are at times very worrying, as noted by a participant, and much work still needs to be done to eliminate the exploitative situations that seem to prevail in certain research settings. In addition, no Indigenous or gender diverse researchers participated in the study. Given the ethical issues and systemic injustices that many people from these groups face in Canada (Drolet & Goulet, 2018 ; Nicole & Drolet, in press ), research that gives voice to these researchers would be relevant and contribute to knowledge development, and hopefully also to change in research culture.
Further, although most of the ethical issues discussed in this article may be transferable to the realities experienced by researchers in other countries, the epistemic injustice reported by Francophone researchers who persist in doing research in French in Canada – which is an officially bilingual country but in practice is predominantly English – is likely specific to the Canadian reality. In addition, and as mentioned above, recruitment proved exceedingly difficult, particularly amongst researchers. Despite this difficulty, we obtained data saturation for all but two themes – i.e., exploitation of students and ethical issues of research that uses animals. It follows that further empirical research is needed to improve our understanding of these specific issues, as they may diverge to some extent from those documented here and will likely vary across countries and academic research contexts.
This study, which gave voice to researchers, REB members, and ethics experts, reveals that the ethical issues in research are related to several problematic elements as power imbalances and authority relations. Researchers and research assistants are subject to external pressures that give rise to integrity issues, among others ethical issues. Moreover, the current context of social acceleration influences the definition of the performance indicators valued in academic institutions and has led their members to face several ethical issues, including social, distributive, and epistemic injustices, at different steps of the research process. In this study, ten categories of ethical issues were identified, described and illustrated: (1) research integrity, (2) conflicts of interest, (3) respect for research participants, (4) lack of supervision and power imbalances, (5) individualism and performance, (6) inadequate ethical guidance, (7) social injustices, (8) distributive injustices, (9) epistemic injustices, and (10) ethical distress. The triangulation of the perspectives of different members (i.e., researchers from different disciplines, REB members, research ethics experts, and one research assistant) involved in the research process made it possible to lift the veil on some of these ethical issues. Further, it enabled the identification of additional ethical issues, especially systemic injustices experienced in research. To our knowledge, this is the first time that these injustices (social, distributive, and epistemic injustices) have been clearly identified.
Finally, this study brought to the fore several problematic elements that are important to address if the research community is to develop and implement the solutions needed to resolve the diverse and transversal ethical issues that arise in research institutions. A good starting point is the rejection of the corollary norms of “publish or perish” and “do more, faster, and better” and their replacement with “publish quality instead of quantity”, which necessarily entails “do less, slower, and better”. It is also important to pay more attention to the systemic injustices within which researchers work, because these have the potential to significantly harm the academic careers of many researchers, including women researchers, early career researchers, and those belonging to racialized groups as well as the health, well-being, and respect of students and research participants.
The team warmly thanks the participants who took part in the research and who made this study possible. Marie-Josée Drolet thanks the five research assistants who participated in the data collection and analysis: Julie-Claude Leblanc, Élie Beauchemin, Pénéloppe Bernier, Louis-Pierre Côté, and Eugénie Rose-Derouin, all students at the Université du Québec à Trois-Rivières (UQTR), two of whom were active in the writing of this article. MJ Drolet and Bryn Williams-Jones also acknowledge the financial contribution of the Social Sciences and Humanities Research Council of Canada (SSHRC), which supported this research through a grant. We would also like to thank the reviewers of this article who helped us improve it, especially by clarifying and refining our ideas.
As noted in the Acknowledgements, this research was supported financially by the Social Sciences and Humanities Research Council of Canada (SSHRC).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Any recommendations on where to stay in saint Petersburg for a short visit during world cup. Trustworthy hostel or dorm. I tried to book twice via booking but i got suspecious emails from the hostels asking me to pay by paypal so send the money to their account somewhere outside Russia.
This post was determined to be inappropriate by the Tripadvisor community and has been removed.
Try Hotel Pilau (hostel section as well) on Rubinshteyna St
Found there booking form user friendly —- use their website and not Booking .Com or Trivargo
this time only surburbs might be affordable
Can you tell me best areas for moderate price accomodation in August
Just got back from St Petersburg,stayed at the Altberg at Nevsky 53,which is a couple of doors away from the “Corinthia”
Paid around $100 a night,I’m sure August will be cheaper.
Small 6 room hotel,go through the archway,hotel is set back from the main Nevsky Prospekt,great location,only 15 minute walk up to the Hermitage,5 minutes to the Moscow train station and Galleria shopping center.
In August there should not be a problem finding a Hostel in the city center. Even now there are rooms available in the city center because World Cup fans are moving between cities often so there is a lot of flow in and out every day.
For small hostels, it is not unusual to have payment by PayPal or other on-line payment system because normally they work on cash only basis. Larger established mini-hotels and hostels will have merchant credit card accounts. If you are using one of the major hotel booking engines, it is pretty safe to assume they are a real hotel or hostel. If you are not a member of Couch Surfing you should be for this type of short stays. There are thousands of active members here in this city and the never charge, it is a person to person international travel organization where locals offer their homes, a sofa or spare bedroom just for the fun and interesting interaction with visitors. There are also a lot of AirBnB apartments offered but these are charged for. Apartments are more per night than hostels however but offer privacy and larger space.
Please suggest a good hotel for 4 nights in St Petersburg in end of August close to main attractions and metro.
Thank you in advance.
>>>
No problem, booking.com or hotels.com or any other site will give you hundreds of them.
If the location (5 min walk to metro station), excellent service, delicious food & stylish interiors are your first priority look at Wynwood hotel (4*) /http://wynwood.co/en/about-hotel_en/
We stayed at the Corinthia Hotel St. Petersburg and would highly recommend. Well located, 5 star, great amenities and not too expensive for what it is.
Introduction Intratympanic corticosteroids are commonly used in the treatment of Menière’s disease (MD). However, few and small randomised controlled trials (RCT) on the effectiveness of intratympanic corticosteroids have been performed. A recent Cochrane review suggested that a well-conducted placebo-controlled RCT with a large study population is required to evaluate the effectiveness of the use of intratympanic corticosteroids in MD. The following protocol describes a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial to compare the effectiveness of methylprednisolone (62.5 mg/mL) to a placebo (sodium chloride 0.9%).
Methods and analysis We aim to recruit 148 patients with unilateral MD from six hospitals in the Netherlands. Patients will be randomly assigned to either the methylprednisolone or the placebo group. Two injections will be given, one at baseline and one after 2 weeks. Follow-up assessments will be done at 3, 6, 9 and 12 months. The primary outcome will be the frequency of vertigo attacks. Attacks will be evaluated daily with the DizzyQuest app. Secondary outcomes include hearing loss, tinnitus, health-related quality of life, use of co-interventions and escape medication, (serious) adverse events and cost-effectiveness. These will be evaluated with audiometry and multiple commonly used, validated questionnaires. For the primary and secondary outcomes mixed model analysis, generalised estimating equation analysis and logistic regression analysis will be used.
Ethics and dissemination This study was submitted via the Clinical Trials Information System, reviewed and approved by the Medical Research Ethics Committee Leiden The Hague Delft and the local institutional review board of each participating centre. All data will be presented ensuring the integrity and anonymity of patients. Results will be published in scientific journals and presented on (inter)national conferences.
Trial registration number This study is registered at ClinicalTrials.gov Protocol Registration and Results System, with the registration ID: NCT05851508 .
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ .
https://doi.org/10.1136/bmjopen-2023-076872
Request permissions.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
In this randomised placebo-controlled study, both participants and clinicians will remain blinded throughout the follow-up period, therefore, minimising the risk of bias.
The prospective design with patients daily recording their vertigo attack directly in an app lowers the risk of missing data and recall bias.
This study includes a rather large patient population of 148 patients.
Vestibular migraine and Menière’s disease (MD) share multiple features in terms of clinical presentation and other symptomatology, distinguishing between the two could be challenging and therefore, could form a possible limitation in this study.
Subanalyses on clinical subgroups of MD (autoimmune, familial and MD+migraine) will be difficult to conduct because many patients cannot be classified in a subgroup or are part of multiple subgroups.
Menière’s disease (MD) is a clinical condition characterised by tinnitus and aural fullness, low-frequency to mid-frequency sensorineural hearing loss, and spontaneous episodes of vertigo that can last 20 min to 12 hours. 1 Patients with MD experience a worse quality of life than healthy patients due to vertigo, tinnitus and hearing loss. 2 In addition, higher levels of anxiety and depression are seen in patients with MD. 3
Although its aetiology is unknown, endolymphatic hydrops (EH) is thought to be associated with MD. Almost all patients with MD have EH, but not all patients with EH have symptoms of MD. It is unknown if EH is a result of MD or a causal factor for MD. 4 5 Until this day, there is no agreement as to the ideal treatment of MD due to the lack of evidence for the effect of various therapies. Current treatment consists of dietary and lifestyle modifications, oral diuretics, vestibular rehabilitation for chronic imbalance, intratympanic therapy and/or ablative surgery. 1 With intratympanic gentamicin and corticosteroid injections, the drug is directly delivered into the middle ear, from where it will be absorbed in the inner ear. Unlike gentamicin, corticosteroid therapy does not carry a risk of causing hearing loss. Therefore, it is currently the first step of standard care in the treatment of MD. 1 Although the mechanism of action of steroids on the inner ear remains speculative, it may improve cochlear blood flow and stabilise the vascular endothelium which enhances fluid homeostasis by upregulation of cochlear ion gene expression. 6 Recently, a Cochrane review was published evaluating the use of intratympanic corticosteroids in MD. 7 In this review, 10 randomised controlled trials (RCTs) and quasi-RCTs comparing intratympanic corticosteroids, all using dexamethasone, compared with either placebo or no treatment were included. The authors found that the evidence for the use of dexamethasone is uncertain. Intratympanic dexamethasone injection may marginally reduce the frequency of vertigo attacks. Regarding hearing and tinnitus, improvement was seen but without statistical significance.
The most commonly intratympanically administered corticosteroids are dexamethasone and methylprednisolone. 1 Phillips et al 8 determined the efficacy of intratympanic OTO-104 (a sustained-released dexamethasone hydrogel) for the treatment of MD, in three double-blind, placebo-controlled RCTs, with a total of 165, 174 and 148 patients respectively. OTO-104 showed numerically larger decreases in definitive vertigo days compared with placebo across all three studies. However, in only one study, this difference was statistically significant. Pharmacokinetic studies show that dexamethasone phosphate has molecular and pharmacokinetic characteristics that complicate its use as a topical therapy for hearing disorders, which may explain its questionable effectiveness. 9 An animal study found that the concentrations of methylprednisolone are higher and have longer duration in perilymph and endolymph compared with dexamethasone and hydrocortisone, and therefore, could be a more effective drug. 10 Typically, soluble forms of methylprednisolone are administered and expected to be less permeable through the membranous boundaries compared with the less polar forms. However, there is no data whether these soluble forms are metabolised to the base form in the ear and if they are, at what rate. 9 Despite the fact that little is known about the pharmacokinetics of methylprednisolone, there are clinical indications of its effectiveness. 11 12 Cao et al 12 performed a literature review and demonstrated that methylprednisolone is more effective than dexamethasone in a clinical setting.
Although in the last decade, there is an increasing tendency and emerging evidence for the use of intratympanic steroids, no large RCT on the effectiveness of intratympanic methylprednisolone in MD has been conducted. 13 A meta-analysis published in 2021 included eight studies comparing intratympanic gentamicin to intratympanic corticosteroids, in which gentamicin appeared to be superior in terms of control of vertigo attacks. 14 However, gentamicin is known to be ototoxic and can induce hearing loss. Patel et al 15 compared intratympanic gentamicin injections to methylprednisolone injections in a double-blind RCT with a 24-month post-treatment follow-up. Vertigo attacks decreased in both groups, indicating a treatment effect. However, no placebo group was involved and the sample size was relatively small (n=60).
In conclusion, there is a need of solid evidence on the effectiveness of intratympanic steroids in MD. Until now, the effectiveness of methylprednisolone has not been investigated by means of a placebo controlled RCT. Therefore, a well-conducted RCT with a large study population and a long follow-up period is now required to evaluate the effectiveness of intratympanic methylprednisolone in MD. In this protocol, we present the methods of a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial evaluating the effectiveness of intratympanic injections with methylprednisolone vs placebo in the treatment for MD patients.
In this phase 3, multicentre, double-blind, placebo-controlled randomised trial, the effect of two intratympanic methylprednisolone sodium succinate 62.5 mg/mL (Solu-Medrol in Act-O-Vial, Pfizer BV) injections 14 days apart is compared with two placebo (ie, sodium-chloride 0.9%) injections with the same time interval on vertigo attacks in patients with MD. Parallel groups will be randomly assigned to one of both arms and outcomes will be measured during a 1 year follow-up period.
To ensure transparency and completeness in this clinical trial, the SPIRIT and CONSORT checklists are provided in online supplemental files 1 and 2 .
Study subjects.
Patients with MD will be recruited by six participating sites in the Netherlands and will be approached by their own ENT specialist and informed about this trial. After a 1 week reflection period, informed consent forms can be signed. Baseline and outcome data will be extracted from participants’ electronic medical records and collected in the cloud-based clinical data management platform Castor EDC (version v2023.1.0.1, LUMC).
In order to be eligible for the study, a study subject needs to have unilateral, definite MD according to the diagnostic criteria derived from the American Academy Otolaryngology Head and Neck Surgery, Classification Committee of the Bárány Society, European Academy of Otology and Neurotology and International Classification of Vestibular Disorders published in 2015. 16 The criteria for definite MD are:
Two or more spontaneous episodes of vertigo, each lasting 20 min to 12 hours,
Audiometrically documented low-frequency to medium-frequency sensorineural hearing loss in one ear, defining the affected ear on at least one occasion before, during or after one of the episodes of vertigo,
Fluctuating aural symptoms (hearing, tinnitus or fullness) in the affected ear (not better accounted for by another vestibular diagnosis).
Other inclusion criteria are:
Age >18 years at the start of the trial.
≥ 4 vertigo attacks over the last 6 months.
Willing to adhere to daily completion of study questionnaires using the DizzyQuest app and to the follow-up assessments.
Study subjects who meet any of the following criteria will be excluded:
Bilateral MD.
Severe disability (eg, neurological, orthopaedic, cardiovascular) or serious concurrent illness that might interfere with treatment or follow-up.
Active additional neuro-otologic disorders that may mimic MD (eg, vestibular migraine, recurrent vestibulopathy, phobic postural vertigo, vertebro-basilar TIAs, acoustic neuroma).
Otitis media with effusion based on tympanogram results.
History of intratympanic injections with corticosteroid less than 6 months ago.
History of intratympanic injections with gentamicin or ear surgery for treating MD.
Pregnant women or nursing women.
A sample size calculation was performed based on recommendations as summarised in the Clinical Practice Guideline for Menière’s disease. 1 An expected proportion of subjects achieving vertigo control of 87.5% was assumed for methylprednisolone treatment compared with an assumed 67.5% for placebo, that is, a difference in treatment effect of 20%. With a statistical power (1-β) of 80% and a type 1 error (α) of 5%, 67 patients per group are required. With an estimated 10% loss-to-follow-up, 74 patients will be included in each arm, giving a total sample size of 148. In total, over the six participating centres, 340 MD patients yearly visit the Otolaryngology department and will be screened for the trial. It is expected that 15% will meet the inclusion criteria and will be willing to participate. This will result in approximately 50 eligible patients for inclusion per year.
Subjects will be randomly assigned to either methylprednisolone or placebo with a 1:1 allocation as per computer-generated random sequence, stratified by site generated by Castor EDC. Blinding will be maintained until all subjects have finished their treatment phases. All study participants, participating medical professionals and outcome assessors will be blinded. The independent epidemiologist and pharmacy personnel will both be unblinded during randomisation and therapy allocation.
After a 1 week reflection period and agreement with trial participation by means of signing the informed consent, a patient will be seen at the study site. Standard inquiries about the patient’s demographics, family history and medical history—particularly regarding any history of autoimmune disease and migraine—are made at the informed consent visit. Thereafter, patients will receive an intratympanic injection with either methylprednisolone or placebo at day 1 and day 15 with a window of 3 days. The patient is lying down in supine position with their head rotated to the side and prior to the intratympanic injection, the eardrum will be anaesthetised. Thereafter, a myringotomy is being performed and a small spinal puncture needle is passed through the tympanic membrane to inject fluid into the middle ear cavity at the level of the round window. The patient is then required to remain on their side without swallowing for 30 min.
At baseline, results of MRI must be available to make sure other causes of disease are ruled out. 17 To assess the vestibular function of the horizontal semicircular canals, the caloric test and video head impulse test (vHIT) will be performed. To evaluate the anterior and posterior semicircular canals, the vHIT will be conducted at baseline in order to assess the presence of vestibular hypofunction or areflexia.
During a follow-up period of 1 year, overall well-being and vertigo attacks are being assessed daily with the aid of the DizzyQuest app. Two telephone contacts will take place at 3 and 6 months to assess possible (serious) adverse events, DizzyQuest app compliance and the use of escape medication or co-interventions. A physical follow-up visit in the outpatient clinic will be scheduled at 6 and 12 months. During these outpatient clinic visits, additional audiometry and multiple questionnaires concerning tinnitus, dizziness and quality of life will be filled-in. An overview of follow-up moments of the corresponding outcomes and a flowchart of the study procedure are presented in table 1 and figure 1 , respectively.
Flowchart of the study procedure. IT, intratympanic.
Overview of follow-up moments of the corresponding outcomes
The primary outcome measure will be defined by the class of vertigo as defined by the AAO HNS 1995 guideline. The class of vertigo is defined by the average number of attacks per month during 6 and 12 months after treatment divided by the number of attacks 6 months before treatment times 100. As a result, the following class of vertigo is defined:
A: Complete control of vertigo=0.
B: Substantial control of vertigo=1–40.
C: Limited control of vertigo=41–80.
D: Insignificant control of vertigo=81–120’.
E: Worse control of vertigo >120.
Moreover, the daily attack vertigo frequency will be monitored with the aid of the DizzyQuest app (Psymate 2). 18 19 The DizzyQuest app will be used to track the primary outcome measure, the frequency of dizziness attacks. Patients will answer daily questionnaires about their health and well-being and patients can report vertigo attacks at any time using the DizzyQuest app. Additionally, the Dizziness Handicap Inventory (DHI) questionnaire will be administered at baseline, after 6 months and after a year to assess how dizziness affects daily life. 20 The effect of the injections in the DHI will be reported as raw data, as well as change in handicap category (mild handicap, moderate handicap or severe handicap) related to improvement, unchanged or worsened.
The following secondary outcomes will be measured.
Pure tone audiometry will be performed at baseline, after 6 months and after a year. In line with the guideline of AAO HNS 1995 guideline, 17 we will use the average scores of four-tone audiometry at 0.5, 1, 2 and 3 kHz and we will assess the word recognition scores as the percent correct score at the presentation level in decibel. A decrease of ≥10 dB or a change in word recognition score of ≥15% points is considered clinically significant.
The Tinnitus Functional Index (TFI) measures the impact of tinnitus on daily life. 21 This survey will be administered at baseline, after 6 months and after a year. One point decrease of increase will be defined as improved or worsened tinnitus respectively. 22
Apart from the DHI and TFI, the EuroQol 5 dimension (EQ-5D) and EuroQol – Visual Analogue Scale (EQ-VAS) questionnaires will be used to measure quality of life at baseline, after 6 and 12 months. 23 24 These questionnaires are standardised tests of health status that are used in economic and clinical evaluations.
In case participants remain suffering from intolerable vertigo attacks, regardless of which group they are allocated to, the use of metoclopramide and co-interventions such as intratympanic injections of gentamicin or methylprednisolone will be allowed and documented during the follow-up period. This will be based on experience of participants’ vertigo frequency and shared decision making. If patients receive additional treatment, they will not be unblinded.
Patients will be informed that Adverse Events, Serious Adverse Events and Suspected Unexpected Serious Adverse Reactions must be reported as soon as possible to their ENT-surgeon or research nurse. Additional queries are made at 3, 6, 9 and 12 months to ensure that they did not fail to report occurrences. These events will be registered throughout the trial in Castor EDC. Each serious adverse event must be reported to the sponsor within 24 hours after the physicians’ knowledge. In the event that patient safety is compromised, patients can be unblinded.
Cost-effectiveness will be assessed from both a healthcare and societal cost-utility perspective, where cost per avoided vertigo attack and cost per Quality Adjusted Life Year (QALY), respectively, will be used as the metrics. MD-related medical expenses, other healthcare expenses and the cost of lost productivity will all be included in the estimated societal cost, which will be calculated using the iMTA Medical Consumption Questionnaire (iMCQ) and IMTA Productivity Cost Questionnaire (IPCQ).
Ordinal regression using mixed model analysis will be used to analyse the primary outcome (ie, class of vertigo). In addition, generalised estimating equation analysis of the actual vertigo attacks recorded using the DizzyQuest app will be used to estimate the incidence rate ratio for comparison between the methylprednisolone and placebo groups. A decrease of 100% is considered total control of vertigo episodes, while a reduction of >40% is considered a substantial and thus clinically relevant reduction. 17
Mixed model analysis will be used to analyse differences in the questionnaire scores (DHI, TFI, FLS, eQ-5D/VAS, iMCQ, iPCQ) between the two groups. Logistic regression analysis will be used to analyse the remaining secondary outcomes (incidence of escape interventions, hearing loss and adverse events). A reduction in hearing of 10 decibels or a 15% change in word recognition will be regarded as a clinically significant difference. 17
Subgroup analyses will be performed with regard to sex, duration of the disease and the type of MD (delayed MD, familial MD and autoimmune MD). These subgroups will be defined as described in Frejo et al . 25 Two sensitivity analyses will be carried out in addition to the intention to treat analysis: a per protocol analysis in which patients who received additional co-interventions to achieve vertigo control are excluded; and an as-treated analysis in which participants who received additional co-interventions are analysed.
In order to evaluate the average costs and outcomes between the methylprednisolone and placebo groups for the cost-effectiveness analysis, intention-to-treat and net-benefit analysis will be used. For all statistical analysis, multiple imputation to adjust for missing data will all be used. 26 QALYs will be calculated using the Dutch tariff for the EuroQoL EQ-5D-5L 23 and as sensitivity analysis, the visual analogue scale valuing health, with power-transformation. 27 All outcomes with corresponding statistical analysis methods are summarised in table 2 . A p value <0.05 will be considered as statistically significant for all analyses and will be performed using SPSS V.25 or higher (SPSS Chicago Illinois, USA).
Outcomes with corresponding statistical analysis method
The PREDMEN trial is supported by the Dutch Association for the hard of hearing, and more specifically, its Committee Dizziness and Balance (Commissie Duizeligheid en Evenwicht van Hoormij-NVVS) and the Dutch association for psychological healthcare and social services for patients with SNHL and tinnitus (GGMD). Both organisations are involved in the realisation of the trial, the writing process and implementation of trial results. Moreover, they will serve as a sounding board for MD patients participating in this trial and one patient representative will be a member of the steering committee. In line with their suggestions, patients will be involved in every stage of the research.
The PREDMEN trial was submitted via the Clinical Trial Information System (CTIS), with CTIS number: 2023-503340-13-00 , reviewed by the Medical Research Ethics Committee Leiden The Hague Delft (MREC LDD), and authorised for execution in the Netherlands under the European Clinical Trial Regulation (ECTR). Additionally, the institutional research board and the Board of Directors of each participating centre (Franciscus Gasthuis & Vlietland, Gelre ziekenhuizen, HagaZiekenhuis, Leiden University Medical Centre, Maastricht University Medical Centre, Medisch Spectrum Twente) individually reviewed and approved the study. The study is conducted in accordance with the principles outlined in the Declaration of Helsinki (October 2013), the Medical Research Involving Human Subjects Act (WMO, 26 February 1998), the International Conference on Harmonisation Good Clinical Practice (ICH GCP, November 2016) guidelines, and any other applicable guidelines, regulations and Acts.
Minor complications such as persistent membrane perforation (5.9%) and otitis media (7%) can occur. 7 28 29 Safety risk will be comparable to normal clinical practice and it is not expected that significant adverse events will be seen in the intervention arm. ENT specialists are experienced with intratympanic injections due to its application in patients with sudden deafness. Since the intervention is characterised as a low risk profile study, no Data Safety Monitoring Board (DSMB) is required. 30 The sponsor will submit a report on the safety of each investigational medicinal product used in the clinical trial through CTIS. Interim analysis will be performed on the primary endpoint when 50% of the patients have been randomised and completed a follow-up of 6 months, where comparability of baseline characteristics will be assessed. In these analyses, differences in vertigo control between the two study arms should not be greater than 45%. In addition, if the difference in vertigo control reveals to be clinically significant (ie, >20%), but ≤20% of the participants in methylprednisolone reach vertigo control, the study will be terminated because of convincing effect of the treatment in the intervention arm.
The handling of personal data complies with the Dutch Personal Data Protection Act (AVG). All data collected for the trial, including but not limited to demographic data, audiological questionnaires and data from the DizzyQuest app will be entered in a ISO 9001 and ISO 27001:2005 certified Castor EDC database (electronic CRF). Data will be protected with a unique subject identification code which is linked to a password protected subject identification list. Only members of the study team, who will be documented on the site signature and delegation log per site, will have access to the study data. The sponsor and investigator will keep a clinical trial master file which will contain the essential documents relating to the clinical trial.
A summary of the results of this study will be submitted to CTIS within 1 year after termination of the trial. Results will also be published in scientific journals and presented on (inter)national conferences. All information that will be presented will be done so in a way that integrity and anonymity of patients are ensured. All data will be stored for 25 years after the last subject has had the last study visit.
This study is registered at ClinicalTrials.gov Protocol Registration and Results System, with the registration ID: NCT05851508 .
Patient consent for publication.
Not applicable.
Contributors The conception and design of the study were developed by BvE, BMM, PPvB and TDB. The drafting of the original protocol was done by BvE, BMM, TDB and TRS. The coordination of the study was carried out by BvE, BMM, MMEB and TDB. Patient recruitment and collection of data were performed by BvE, MMEB, PPvB and TDB. The statistical analysis plan was designed by TRS. The present manuscript was drafted by MMEB. The funding was obtained by BvE, BMM and TDB. All authors read and approved the final manuscript prior to submission for publication. BvE and TDB acted as the guarantors of this study.
Funding This work was supported by the subsidy from the healthcare research the Netherlands: ZonMw with grant number: 10140022110009.
Competing interests None declared.
Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
IMAGES
VIDEO
COMMENTS
Welcome to the website of the Acadia University Research Ethics Board (REB). Please explore the links in the left column. To contact the REB via its Chair: Dr. Stephanie Jones Email: [email protected] Telephone: 902.585.1495. Mailing address Research Ethics Board 214 Horton Hall Acadia University
How to apply for ethics approval. Step 1: Prepare your application. All applications must be submitted electronically. The application form is a downloadable Microsoft Word document containing expandable cells into which you can easily enter the required information. For each project, the researcher must prepare an application containing the ...
Research Ethics Board. Forms. Download application form (MS Word) Acadia ethics review template (PDF) - Provided for your information only: This is the internal form that the REB's Faculty Representatives use when reviewing applications. ... Acadia University is located in Mi'kma'ki, the ancestral and unceded territory of the Mi'kmaw nation. ...
Research Ethics Board; Senate Research Committee; Acadia Biosafety Committee; Strategic Research Plan (PDF) Contact. Research, Innovation, and Graduate Studies Office 214 Horton Hall 18 University Avenue, Box 70 Wolfville, Nova Scotia, B4P 2R6 [email protected] 902-585-1498 .
(either the Ethics committee in the Department of Sociology or if your research is receiving university ethics approval then you say, the chair of Acadia University's Research Ethics Board, Dr. Stephen Maitzen ([email protected] or 902-585-1407)." Then, on a separate page you need to have a signed consent form. See page 8 for sample wording.
Undergraduate Student Research Funding. Acadia HSRA funding (up to $5000 per awardee) supports both salary and mandatory employer related costs for up to 10 weeks at ~30 hours per week. At the time of application, eligible applicants must: • Have completed two or three years of full-time university study; • Be registered in an Honours ...
Chair, Acadia University Research Ethics Board I thank the editors for inviting me to discuss the role of the Research Ethics Board (REB) and the relationship between academic freedom and the new ethical guidelines governing research on human subjects. My opinions reflect my experience in overseeing the operations of the REB and trying to ...
Research Ethics Board gives the student clearance to proceed.. The supervisor takes responsibility to place a copy of the proposal and the signed Proposal Acceptance Form in the student's file secured in the SOE main office. Note: Completion of the Thesis Proposal Acceptance Form must precede an application to the Research Ethics Board. 9.
The following types of research require ethics approval from the Research Ethics Board before the research is begun: All research that involves living human subjects, except as stipulated below; ... the REB of Mount Allison University will serve as the appeals board for Acadia University in a reciprocal relationship. Both universities have ...
The principal investigator obtained ethics approval for this project from the Research Ethics Board of the Université du Québec à Trois-Rivières (UQTR). All members of the research team signed a confidentiality agreement, and research participants signed the consent form after reading an information letter explaining the nature of the ...
Like Nowhere Else. Acadia University 15 University Avenue Wolfville, Nova Scotia B4P 2R6 Canada
As required by Canada's gran ng councils, Acadia's Research Ethics Board (est. 1999) meets monthly 12 mes per year to review applica ons for ethics approval that relate to research involving human subjects or involving data collected from human subjects. This body has the power to approve, rejec t, or to propose modifica ons to such
Any recommendations on where to stay in saint Petersburg for a short visit during world cup. Trustworthy hostel or dorm. I tried to book twice via booking but i got suspecious emails from the hostels asking me to pay by paypal so send the money to...
Register for and attend Experience Acadia Day on February 23, 2024 AND. Accept their offer to attend Acadia University starting in the Fall 2024 by 11:59 p.m. AST on February 23, 2024. Employees of Acadia University, and members of their immediate family (ie: spouse, child, sibling, parent) and/or any member of their immediate household or who ...
Yes. It is acceptable to conduct a single session of data-collection, using a single consent form, to obtain data for use by multiple researchers pursuing separate research projects, provided that the consent form (1) complies with the requirements of the Tri-Council Policy Statement, (2) makes clear all of the purposes for which data are being collected, and (3) clearly identifies the ...
As per the Tri-Agency Framework: Responsible Conduct of Research (2021), Responsible Conduct of Research (RCR) is the responsibility of researchers, institutions, and the Tri-Agencies."For researchers, this implies duties of honest and thoughtful inquiry, rigorous analysis, commitment to the dissemination of research results, and adherence to the use of professional standards (2021)."
Saint Petersburg Shredding - (727)286-3595. When it comes to Florida mobile shredding Legal Shred Inc. is the place to go. With the most advanced shredding equipment on the market today Legal Shred can visit your location and shred 10 boxes in 3 minutes.
Save up to $5,881 on one of 356 used GMC Acadias for sale in Saint Petersburg, FL. Find your perfect car with Edmunds expert reviews, car comparisons, and pricing tools.
Keeping Students Informed. View class and courses schedules for upcoming terms at . You can use this link to filter courses by term, sessions, modality, campus and more. is SPC's platform for managing and sharing course syllabi. Initially introduced Summer 2023, we are now focusing on achieving full implementation across all courses by Fall 2024.
Acadia University Research Ethics Board - Application Review Template (Revised January 2023) 8.4(b): For research outside Canada, application includes: rules and review requirements (if any) at remote site; names and contact info for remote REB (or equivalent), if known.
Ethics and dissemination This study was submitted via the Clinical Trials Information System, reviewed and approved by the Medical Research Ethics Committee Leiden The Hague Delft and the local institutional review board of each participating centre. All data will be presented ensuring the integrity and anonymity of patients. Results will be published in scientific journals and presented on ...
In 2025, Acadia will be a university that is clearly differentiated within the Canadian post-secondary landscape. Our faculty will be known as leading researchers in their disciplines and the value to students, alumni, and potential employers of its liberal education model will be widely recognized. We will be an acknowledged leader in reducing ...
Research Ethics Board. Dates of meetings. Scheduled meetings for 2023-2024: September 5, October 5, November 2, December 7, January 10, February 7, March 6, April 3, May 1, ... Acadia University is located in Mi'kma'ki, the ancestral and unceded territory of the Mi'kmaw nation. ...
The Acadia 2025 Task Force will be engaged in Strategic Impact Groups reporting up to the Leadership Forum. The LF comprises the President (Chair), SLT members, Deans of the Faculties, Executive Directors and Directors, and the Indigenous Advisor. The Acadia 2025 Operational Plan will be the guiding tool to implement the goals and objectives of ...